Clinical Trials Directory

Trials / Unknown

UnknownNCT05417373

Algorithms to Diagnose Pulmonary Arterial Hypertension

Development and Validation of a Radiomics-based Diagnosis Model for Pulmonary Arterial Hypertension

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The investigators intend to evalute the value of radiomics signature of pulmonary vessels from chest computed tomography (CT) for dianosis and prognosis of pulmonary arterial hypertension.

Detailed description

Pulmonary arterial hypertension (PAH) is a heterogeneous disorder composed of varying pathobiology that may involve multiple clinical conditions. Computed tomography (CT) is a minimally invasive imaging technique capable of providing both high contrast and high resolution detail of the lungs and arteries. Application of radiomics as prognosis and diagnosis tools could quantifies high-dimensional features from CT data to investigate vescualr heterogeneity.Development and validation of PAH diagnosis Algorithms based on radiomics may serve as a complementary readout to current CT-based metrics and provide valuable evidence to make the treatment management decision in early PAH.

Conditions

Interventions

TypeNameDescription
OTHERcalculated radscoreThe development cohort is case\_control research. The validation cohort is prospective study to test the accuracy of calculated radscore based on diagonisis model.

Timeline

Start date
2019-01-17
Primary completion
2022-12-01
Completion
2023-06-01
First posted
2022-06-14
Last updated
2022-06-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05417373. Inclusion in this directory is not an endorsement.